Scarica l'app Stockscreener
1.01
4.72%
-0.05
Dopo l'orario di chiusura:
1.05
0.04
+3.96%
An 2 Therapeutics Inc Azioni (ANTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.76%
18.30
|
18.82 | 18.18 | 16.60 | 16.04 |
| Operating Income/Loss |
2.76%
-18.30
|
-18.82 | -18.18 | -16.60 | -16.04 |
| Income/Loss From Continuing Operations Before Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
| Income/Loss From Continuing Operations After Tax |
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
|
Net Income/Loss
|
1.66%
-16.62
|
-16.90 | -16.71 | -15.80 | -15.32 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
| Diluted Average Shares |
1,340%
29.76
|
2.0676 | 25.65 | 19.50 | 19.39 |
| Basic Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
| Diluted Earnings Per Share |
7.69%
-0.56
|
-0.52 | -0.65 | -0.81 | -0.79 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
6.21%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):